Publications
- Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia2013 | Second Faculty of Medicine
- Assessment of extramedullary leukemic infiltration in childhood acute lymphoblastic leukemia and its clinical use. Review and original data2012 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis2011 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- The incidence and treatment of relapse of childhood acute lymphoblastic leukemia in the Czech Republic between 1990-20002003 | Second Faculty of Medicine
- International note - Treatment of Czech children with acute lymphoblastic leukemia: A report of the Czech working group for pediatric hematology2002 | Second Faculty of Medicine
- Acute lymphoblastic leukemia in infants2002 | Second Faculty of Medicine
- Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia2000 | Second Faculty of Medicine
- Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia1999 | Second Faculty of Medicine
- TEL/AML1 Positivity in Childhood ALL: Average of better Prognosis? Czech Paediatric Haematology Working Group1999 | Second Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
Loading network view...